Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s LymphomaThomas E. Witzig, Christine A. White, Leo I. Gordon et al.|Journal of Clinical Oncology|2002Cited by 1.2k
Rituximab: Ongoing and future clinical developmentAntonio J Grillo-López, Mark Benyunes, Eric Hedrick et al.|Seminars in Oncology|2002Cited by 185
Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neckSusan G. Urba, John W. Gyves, C. Cripps et al.|Cancer Chemotherapy and Pharmacology|1992Cited by 43